Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology/Urology | Psychiatry/Psychology | Obstetrics/Gynecology | Endocrinology
Disease Category: Sexual Dysfunction
Trial Information
Hypoactive Sexual Desire Disorder
The study will help evaluate the long-term safety and efficacy of daily topical applications of LibiGel, an investigational drug, compared to placebo gel (an inactive substance) in the treatment of Hypoactive Sexual Desire Disorder in postmenopausal women. The study consists of a screening period of up to 4 weeks and a 60-month treatment period. Subjects will complete 9 office visits and 5 telephone contacts during the course of the study. Also, the study will follow subjects for heart blood vessel disease events and breast cancers for up to 5 years.
Patient Inclusion Criteria:
- Natural menopausal women 50 years of age or older with a diagnosis of HSDD
- Subjects with hysterectomy only must meet following menopause criteria: 50 to 54 years must be experiencing hot flushes or receiving estrogen therapy for hot flushes
- At least one risk factor for heart blood vessel disease including: 70 years or greater, type 2 diabetes, high blood pressure, smoking, or taking medication to treat high blood pressure
- Agrees to provide research site with contact information throughout the study period, which will last up to 5 years
Additional inclusion and exclusion criteria apply and will be reviewed with you.
Nicole, Carolyn and Diane, Research Staff
Coastal Connecticut Research, LLC
342 Montauk Avenue
New London, CT 06320
Phone: 860-443-4567
Fax: 860-442-7270
EMail: ccrvolunteer@gmail.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
